Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Cluster of Excellence CellNetworks,
Department of Infectious Diseases,
Virology,
Cluster of Excellence CellNetworks, Department of Infectious Diseases, Virology
Ellen Wiedtke has not added Biography.
If you are Ellen Wiedtke and would like to personalize this page please email our Author Liaison for assistance.
Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2017 | Pubmed ID: 28137845
Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
Journal of virology 10, 2017 | Pubmed ID: 28768875
Impact of the Assembly-Activating Protein on Molecular Evolution of Synthetic Adeno-Associated Virus Capsids.
Human gene therapy 01, 2019 | Pubmed ID: 29978729
AAVvector-mediated in vivo reprogramming into pluripotency.
Nature communications 07, 2018 | Pubmed ID: 29985406
A Robust and All-Inclusive Pipeline for Shuffling of Adeno-Associated Viruses.
ACS synthetic biology 01, 2019 | Pubmed ID: 30513195
Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening.
Molecular therapy : the journal of the American Society of Gene Therapy 04, 2020 | Pubmed ID: 32105604
The angiopoietin-Tie2 pathway regulates Purkinje cell dendritic morphogenesis in a cell-autonomous manner.
Cell reports 08, 2021 | Pubmed ID: 34407407
Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 05, 2022 | Pubmed ID: 35038579
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders.
Science advances 09, 2022 | Pubmed ID: 36129972
Heidelberg University
University of Heidelberg
Eike Kienle*,1,
Elena Senís*,1,
Kathleen Börner2,
Dominik Niopek1,
Ellen Wiedtke1,
Stefanie Grosse1,
Dirk Grimm1
1Cluster of Excellence CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University,
2Department of Infectious Diseases, Virology, Heidelberg University
Kleopatra Rapti1,2,
Olena Maiakovska1,2,
Jonas Becker1,2,
Joanna Szumska1,2,
Margarita Zayas1,2,
Felix Bubeck1,2,
Jixin Liu1,2,
Emma Gerstmann1,2,
Chiara Krämer1,2,
Ellen Wiedtke1,2,
Dirk Grimm1,2,3,4,5
1Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, University of Heidelberg,
2BioQuant Center, BQ0030, University of Heidelberg,
3, Cluster of Excellence CellNetworks,
4, German Center for Infection Research (DZIF),
5, German Center for Cardiovascular Research (DZHK)
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados